Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia (Q33401630)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

author name string

Tony Tremblay

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Isabelle Paré

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Renée Bazin

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

261-269

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Effect of intravenous immunoglobulin in immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Are aggregates of IgG the effective part of high-dose immunoglobulin therapy in adult idiopathic thrombocytopenic purpura (ITP)?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Immune complexes as therapy for autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Autoantibody-induced formation of immune complexes in normal human serum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Fc receptors: rubor redux

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Safety of IGIV therapy and infusion-related adverse events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Mechanism of action of IVIG and anti-D in ITP

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Anti-inflammatory actions of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Protective mechanisms of IVIG.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Intravenous immune globulins: an update for clinicians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03725.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2012.03725.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33401630&oldid=1606658543"